The first Japanese case with familial combined hypolipidemia without any complications caused by loss-of function variants in ANGPTL3: Case report [PDF]
Hayato Tada +3 more
openalex +1 more source
CRISPR gene editing of angiopoietin-like 3: toward one-time precision therapy for dyslipidaemia. [PDF]
Mondal A, Misra A.
europepmc +1 more source
Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk [PDF]
Fredrik Landfors +4 more
openalex +1 more source
RNA-Targeted Therapeutics for Lipid Metabolic Disorders: From Bench to Bedside. [PDF]
Ali I, Qiu J, Cheang WS, Wang G, Xu S.
europepmc +1 more source
ANGPTL3: a therapeutic target for atherosclerosis [PDF]
openaire +1 more source
Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives. [PDF]
Tamehri Zadeh SS, Toth PP, Banach M.
europepmc +1 more source
The Molecular Mechanisms of Metformin's Action on Blood Lipid Profile in Diabetic Patients. [PDF]
Dettlaff-Pokora A, Swierczynski J.
europepmc +1 more source
ANGPTL3, Apo CIII, Leptin and Triglycerides Are Elevated in Metastatic Prostate Cancer. [PDF]
Boulay G +14 more
europepmc +1 more source

